N-(2-(6-Oxo-3-(thiophen-2-yl)pyridazin-1(6H)-yl)ethyl)-1-phenylmethanesulfonamide CAS 946341-79-3
Purity 97%+In StockPharmaceutical Standards
| CAS No. | 946341-79-3 |
| Molecular Formula | C17H17N3O3S2 |
| Molecular Weight | 375.47 g/mol |
| Category | Pharmaceutical Standards / API Standards |
| Availability | In Stock |
Chemical Structure
Description
N-(2-(6-Oxo-3-(thiophen-2-yl)pyridazin-1(6H)-yl)ethyl)-1-phenylmethanesulfonamide (CAS 946341-79-3) is a pharmaceutical standards certified reference material from CATO. Molecular formula: C17H17N3O3S2. Molecular weight: 375.47 g/mol. ISO 17034 accredited production ensures traceable purity and reliable analytical results.
Physical & Chemical Properties
| Molecular Formula | C17H17N3O3S2 |
| Molecular Weight | 375.47 g/mol |
| Purity | 97%+ |
| Storage | Store at 2-8°C, protect from light, keep sealed and dry |
| Solubility (reference) | Soluble in DMSO, DMF, methanol |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Hygroscopic; reseal immediately after opening |
| Degree of Unsaturation (DBE) | 11.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| CAS Registry Year (est.) | 1987 |
| Nitrogen Atoms | 3 |
| Sulfur Atoms | 2 |
Recommended Standards
- Ethyl 5-amino-4-(3-methoxyphenyl)-2-(methylthio)thieno[2,3-d]pyrimidine-6-carboxylate (CAS 301846-06-0)
- N-{2-Cyano-5-[(cyanomethyl)sulfanyl]-4-phenyl-3-thienyl}benzenecarboxamide (CAS 860609-92-3)
- ENMD-2076, >98% (HPLC) (CAS 934353-76-1)
- 2-(4-Bromo-2-chlorophenoxy)-N-methylethanamine (CAS 1001844-58-1)
- N-(5-Amino-2-methylphenyl)-2-(dimethylamino)acetamide (CAS 946753-98-6)
- 1-(2,4-Difluorophenyl)-3-(4-isobutylphenyl)-1H-pyrazole-5-carboxylic acid (CAS 618103-00-7)
- Thymidine, 5'-O-[[4-(1H,1H,2H,2H-perfluorodecyl)phenyl]bis(4-methoxyphenyl)methyl]-, 3'-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite] (CAS 902456-09-1)
- (4-Nitro-1h-pyrazol-1-yl)methanol (CAS 1001518-99-5)
- 4-HPR 65646-68-6 D08JAC Fenretinide Fenretinide (Ewing's sarcoma), Cancer Research UK Fenretinide (ILE formulation), Children's Hospital LA Fenretinide (intralipid emulsion formulation), Children's Hospital of Los Angeles Fenretinide (intravenous emulsion, lymphoma/solid tumors/pediatric neuroblastomas/pediatric leukemia), CerRx Fenretinide (intravenous, cancer), SciTech Development Fenretinide (iv), Children's Hospital LA Fenretinide (oral powder/Lym-X-Sorb, neuroblastoma), BioMolecular Products Fenretinide (oral, AMD), Sytera Fenretinide (pulmonary Pseudomonas aeruginosa infections in cystic fibrosis), McGill University Fenretinide (soft gel capsule, AMD), ReVision Therapeutics Fenretinide (soft gel capsule, AMD), Sirion Fenretinide (topical, actinic keratosis and cancer), SciTech Development LXS/4-HPR N-(4-hydroxyphenyl)retinamide RT-101 ST-602 SYT-101 (CAS 65646-68-6)
- Semaglutide impurity 267 (CAS CATO-C4X-2226267)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 13829788188 / jacky.chen@cato-chem.com